Hernday Natasha (CIK 1780547) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-14). Recent activity: Sell XOMA (9,304 shares), Sell XOMA (4,000 shares), Buy JANX (5,500 shares), Buy XOMA (3,586 shares), Buy JANX (3,750 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-14 | XOMA Royalty Corp (XOMA) | Director | Sell | 9,304 | $0 |
| 2026-07-14 | XOMA Royalty Corp (XOMA) | Director | Sell | 4,000 | $0 |
| 2026-06-12 | Janux Therapeutics, Inc. (JANX) | Director | Buy | 5,500 | $0 |
| 2026-05-26 | XOMA Royalty Corp (XOMA) | Director | Buy | 3,586 | $0 |
| 2025-06-13 | Janux Therapeutics, Inc. (JANX) | Director | Buy | 3,750 | $0 |
| 2025-05-23 | XOMA Royalty Corp (XOMA) | Director | Buy | 5,971 | $0 |
Source: SEC Form 4 filings · as of 2026-07-14